A detailed history of Four Thought Financial, LLC transactions in Alector, Inc. stock. As of the latest transaction made, Four Thought Financial, LLC holds 1,962 shares of ALEC stock, worth $7,985. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,962
Previous 1,962 -0.0%
Holding current value
$7,985
Previous $20,000 5.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 29, 2022

BUY
$13.02 - $20.78 $4,543 - $7,252
349 Added 21.64%
1,962 $28,000
Q3 2021

Nov 12, 2021

BUY
$21.65 - $39.49 $1,991 - $3,633
92 Added 6.05%
1,613 $36,000
Q2 2021

Nov 12, 2021

SELL
$15.5 - $22.48 $155 - $224
-10 Reduced 0.65%
1,521 $31,000
Q1 2021

Nov 12, 2021

SELL
$14.84 - $22.23 $1,840 - $2,756
-124 Reduced 7.49%
1,531 $30,000
Q4 2020

Nov 12, 2021

BUY
$9.4 - $16.7 $15,557 - $27,638
1,655 New
1,655 $25,000

Others Institutions Holding ALEC

About Alector, Inc.


  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $336M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Four Thought Financial, LLC Portfolio

Follow Four Thought Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Four Thought Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Four Thought Financial, LLC with notifications on news.